background image

Dystrophy Clinical Trials

Find clinical trials for Dystrophy. Search for Dystrophy clinical trials in different cities and states across the United States.

Filter
1
Active & ResponsiveNew

Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy

for
Duchenne Muscular Dystrophy (DMD)
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: Male

Age: 8 - 18

Code: NCT07172971

Phase1, Recruiting
Active & Responsive

Wearable Technology to Evaluate Hyperglycemia and HRV in DMD

for
Duchenne Muscular Dystrophy
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: Male

Age: 10+

Code: NCT06124196

Recruiting
Active & Responsive

Trial of Cell Based Therapy for DMD

for
Duchenne Muscular Dystrophy
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 18+

Code: NCT06692426

Phase1, Recruiting
Active & Responsive

Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy

for
Duchenne Muscular Dystrophy
Location: Ottawa, Toronto, London, Vancouver
Sponsor: Italfarmaco

Sex: Male

Age: 9 - 17

Code: NCT05933057

Phase3, Recruiting
Active & Responsive

Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

for
Spinal Muscular Atrophy Type 3,
Location: Boston MA, New York NY, Palo Alto CA
Sponsor: Columbia University

Sex: All

Age: 5+

Code: NCT06839469

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

for
Stargardt Disease, Stargardt Disease 1, Cone Rod Dystrophy,
Location: Boston MA, Baltimore MD, Gainesville FL, Ann Arbor MI,
Sponsor: Ascidian Therapeutics, Inc

Sex: All

Age: 5+

Code: NCT06445322

Recruiting
Active & Responsive

A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)

for
Duchenne Muscular Dystrophy
Location: Calgary, Vancouver
Sponsor: Solid Biosciences Inc.

Sex: Male

Age: 7 - 11

Code: NCT07160634

Phase3, Recruiting
Active & Responsive

Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)

for
Duchenne Muscular Dystrophy (DMD), Muscular Dystrophy, Duchenne,
Location: Hillsborough NC
Sponsor: Dyne Therapeutics

Sex: Male

Age: 4 - 18

Code: NCT07608432

Phase3, Recruiting
Active & Responsive

Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)

for
Tetraplegia/Tetraparesis, Amyotrophic Lateral Sclerosis (ALS),
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 18 - 70+

Code: NCT07521930

Recruiting
Active & Responsive

Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)

for
Muscular Dystrophy, Facioscapulohumeral
Location: Rochester NY, Durham NC, Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 5 - 17

Code: NCT06847282

Recruiting